HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edwin DeJesus Selected Research

Viremia

1/2022Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
1/2014Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial.
6/2013Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edwin DeJesus Research Topics

Disease

39Infections
12/2022 - 10/2003
13HIV Infections (HIV Infection)
05/2024 - 08/2004
7Nausea
01/2020 - 08/2003
4Headache (Headaches)
10/2021 - 01/2018
3Viremia
01/2022 - 06/2013
3Coinfection
01/2020 - 03/2015
3Virus Diseases (Viral Diseases)
11/2013 - 10/2003
3Hypersensitivity (Allergy)
09/2006 - 01/2005
2Injection Site Reaction
01/2024 - 08/2003
2Weight Gain
01/2020 - 06/2007
2Chronic Hepatitis C
01/2017 - 01/2016
2Fibrosis (Cirrhosis)
01/2016 - 03/2015
2Proteinuria
06/2015 - 10/2008
2Cardiovascular Diseases (Cardiovascular Disease)
01/2014 - 06/2013
2Dizziness (Lightheadedness)
06/2012 - 08/2003
2Acquired Immunodeficiency Syndrome (AIDS)
10/2007 - 06/2007
1Dysbiosis
05/2024
1COVID-19
12/2021
1Pain (Aches)
10/2021
1Drug-Related Side Effects and Adverse Reactions
11/2020
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1Hypotension (Low Blood Pressure)
04/2019
1Pulmonary Arterial Hypertension
04/2019
1Myocardial Infarction
01/2018
1Neutropenia
01/2018
1Renal Colic
01/2018
1Hepatitis C
11/2017
1Chronic Hepatitis B
11/2017
1Urticaria (Hives)
01/2017
1Angioedema
02/2016
1Renal Insufficiency (Renal Failure)
06/2015
1Hepatocellular Carcinoma (Hepatoma)
03/2015
1Liver Diseases (Liver Disease)
03/2015
1Persistent Infection
11/2014
1Necrosis
01/2014
1Gilbert Disease
01/2014
1Long Term Adverse Effects
01/2014

Drug/Important Bio-Agent (IBA)

19Emtricitabine (Emtriva)FDA Link
01/2020 - 01/2006
17Tenofovir (Viread)FDA Link
01/2020 - 07/2004
11tenofovir alafenamideIBA
01/2020 - 06/2015
9RNA (Ribonucleic Acid)IBA
01/2024 - 01/2005
8CobicistatIBA
01/2020 - 03/2011
8Ritonavir (Norvir)FDA Link
01/2020 - 05/2006
8efavirenz (Sustiva)FDA Link
01/2017 - 08/2004
7elvitegravirIBA
09/2016 - 03/2011
6Protease Inhibitors (Protease Inhibitor)IBA
01/2018 - 01/2005
5VaccinesIBA
12/2021 - 11/2013
5Lamivudine (Epivir)FDA Link
01/2021 - 08/2004
5abacavir (Ziagen)FDA Link
01/2020 - 01/2005
5TabletsIBA
01/2019 - 03/2011
5Atazanavir Sulfate (Reyataz)FDA Link
03/2014 - 03/2008
4NucleosidesIBA
01/2021 - 09/2004
4bictegravirIBA
01/2020 - 01/2017
4Ribavirin (Virazole)FDA LinkGeneric
01/2017 - 11/2014
4lamivudine drug combination abacavirFDA Link
11/2006 - 05/2006
4Zidovudine (Retrovir)FDA LinkGeneric
11/2006 - 08/2004
3doravirineIBA
01/2021 - 01/2018
3dolutegravirIBA
01/2020 - 01/2017
3Antiviral Agents (Antivirals)IBA
01/2020 - 05/2006
3Reverse Transcriptase InhibitorsIBA
01/2018 - 09/2004
3SimeprevirIBA
01/2017 - 11/2014
3RacivirIBA
06/2012 - 05/2012
3fosamprenavir (Lexiva)FDA Link
03/2008 - 05/2006
2vesatolimodIBA
05/2024 - 01/2021
2Darunavir (Prezista)FDA Link
01/2020 - 01/2018
2CholesterolIBA
01/2020 - 01/2005
2DNA (Deoxyribonucleic Acid)IBA
11/2019 - 11/2013
2Rilpivirine (TMC-278)IBA
01/2017 - 01/2017
2NucleotidesIBA
01/2016 - 09/2004
2SofosbuvirIBA
01/2016 - 11/2014
2CreatinineIBA
06/2015 - 10/2008
2Biomarkers (Surrogate Marker)IBA
01/2014 - 06/2013
2Enfuvirtide (Fuzeon)FDA Link
12/2008 - 08/2003
2LipidsIBA
01/2005 - 07/2004
1Broadly Neutralizing AntibodiesIBA
01/2022
1ChAdOx1 nCoV-19IBA
12/2021
1Monoclonal AntibodiesIBA
10/2021
1islatravirIBA
01/2021
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2021
1GSK-2838232IBA
01/2020
1oxidized low density lipoproteinIBA
01/2020
1fostemsavirIBA
01/2020
1HLA-B Antigens (HLA-B)IBA
01/2020
1IgG Receptors (Fc gamma RI)IBA
11/2019
1Soluble Guanylyl CyclaseIBA
04/2019
1riociguatIBA
04/2019
1cobicistat mixture with darunavirIBA
01/2019
1emtricitabine tenofovir alafenamideIBA
01/2019
1acivicin (AT 125)IBA
01/2018
1elbasvirIBA
03/2015
1grazoprevirIBA
03/2015
1InterferonsIBA
11/2014
1UK 453,061IBA
09/2014
1etravirine (TMC-125)FDA Link
09/2014
1Plasminogen Activators (Plasminogen Activator)IBA
01/2014
1Fibrinogen (Factor I)FDA Link
01/2014
1IDX 899IBA
01/2014

Therapy/Procedure

12Therapeutics
01/2022 - 01/2006
2Art Therapy
05/2024 - 06/2013
1Intravenous Injections
10/2021